Sientra, Inc.
SIEN
SIEN: Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.
moreShow SIEN Financials
Recent trades of SIEN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SIEN's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Systems, methods and devices for subcutaneous target location Feb. 22, 2022
-
Patent Title: Systems, methods and devices for subcutaneous target location Jul. 14, 2020
Federal grants, loans, and purchases
- $15,680 2023-08-08 00:00:00 Agency: Department of Veterans Affairs
- $10,538 2022-12-15 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $30,165 2022-05-13 00:00:00 Agency: None
- $13,440 2022-05-13 00:00:00 Agency: None
- $262,000 2022-04-27 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $30,165 2021-11-16 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2021-08-30 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
Followers on SIEN's company Twitter account
Number of mentions of SIEN in WallStreetBets Daily Discussion
Recent insights relating to SIEN
Recent picks made for SIEN stock on CNBC
ETFs with the largest estimated holdings in SIEN
Flights by private jets registered to SIEN